Clinical Trials Logo

MRI Sedation clinical trials

View clinical trials related to MRI Sedation.

Filter by:
  • None
  • Page 1

NCT ID: NCT04237792 Completed - MRI Sedation Clinical Trials

Safety and Efficacy of Dexmedetomidine (DEX) for Sedation of Subjects ≥1 Month to <17 Years Undergoing MRI Scans

Start date: February 18, 2020
Phase: Phase 4
Study type: Interventional

This is a randomized, double-blind, dose-ranging study of the efficacy and safety of dexmedetomidine (DEX) when used with propofol as needed, for procedural sedation of pediatric subjects ≥1 month to <17 years of age undergoing MRI scans in the US and Japan.

NCT ID: NCT03806777 Not yet recruiting - MRI Sedation Clinical Trials

Intra-nasal Dexmedetomidine for Children Undergoing MRI Imaging

DexmedMRI
Start date: February 2019
Phase: Phase 4
Study type: Interventional

This study aims to assess the use of intranasal dexmedetomidine (IN-dex) as a sole agent in aiding the successful completion of a MRI scans in children. Dexmedetomidine, a routinely used anesthetic agent in our institution, has many benefits including sedation with neuro-protective and respiratory sparing features. We will test its effectiveness in completing MRI scans in children that would otherwise be given a full general anesthetic.

NCT ID: NCT00909935 Terminated - MRI Sedation Clinical Trials

The Pharmacokinetics of Dexmedetomidine in Children

Start date: April 2011
Phase: N/A
Study type: Observational

This study is designed to identify the plasma concentrations which are required to achieve adequate sedation, using a Ramsay Sedation Scale. As an alpha 2 agonist, dexmedetomidine can elicit hemodynamic changes, fluctuations in blood pressure and heart rate. This study will attempt to determine whether these changes can be predicted by plasma concentrations.